Hostname: page-component-848d4c4894-p2v8j Total loading time: 0 Render date: 2024-05-01T11:26:24.824Z Has data issue: false hasContentIssue false
  • English
  • Français

The use of thyroid hormone in the treatment of depression: a review

Published online by Cambridge University Press:  18 September 2015

M. Vegt ,
J.A. Bruijn  and
T.K. Birkenhäger
M. Vegt*
Affiliation:
Psychiatrisch Centrum Joris. Delft
J.A. Bruijn
Affiliation:
Academisch Ziekenhuis Rotterdam Dijkzigt. Hoofd: Prof. Dr. W.J. Schudel
T.K. Birkenhäger
Affiliation:
Academisch Ziekenhuis Rotterdam Dijkzigt. Thans: Psychiatrisch Centrum Bloemendaal. Den-Haag.
*
Buizerdstraat 70. 2665 TG. Bleiswijk
Get access Rights & Permissions [Opens in a new window]

Summary

The writers of this paper made an inventory of the studies on the use of thyroid hormone in the treatment of depression. Fifteen clinical trials (353 patients), published between 1969 and 1987. were found, that can be described, as to their design, in two seperate groups:

One group (7 studies) administers thyroid hormone simultaneously with a tricyclic antidepressant to reach a faster effect of the antidepressant. The other group (8 studies) adds thyroid hormone to a tricyclic antidepressant in patients who fail to respond to this treatment, with the aim to convert therapeutic failure to success. After studying the literature we think we are able to conclude that it can be usefull to combine the antidepressant with thyroid hormone in view of the fact that, in a number of depressed patients, it shortens the duration of the illness. The augmentation of tricyclics by thyroid hormone needs further study.

Keywords

depressionthyroid hormonetricyclic antidepressantsdepressieschildklierhormoontricyclische antidepressiva
Type
Research Article
Information
Acta Neuropsychiatrica , Volume 3 , Issue 2 , June 1991 , pp. 17 - 21
Copyright
Copyright © Scandinavian College of Neuropsychopharmacology 1991

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Literatuur

1.Prange, AJ. Wilson, IC. Rabon, AM. Lipton, MA. Enhancement of imipramine antidepressant activity by thyroid hormone. Am J Psychiat 1969; 126: 457–69.CrossRefGoogle ScholarPubMed
2.Prange, AJ. Lipton, MA. Enhancement of imipramine mortality in hyperthyroid mice. Nature 1962; 196: 588–9.CrossRefGoogle ScholarPubMed
3.Steiner, M. Radwan, M. Elizur, A. Blum, I. Atsman, A. Davidson, S. Failure of L-Triiodothyronine (T3) to potentiate tricyclic antidepressant response. Curr Ther Res 1978; 23/5: 655–9.Google Scholar
4.Feighner, JP. King, LJ. Schuckit, MA. Croughan, J. Briscoe, W. Hormonal potentiation of imipramine and ECT in primary depression. Am J of Psychiat 1972: 128/10: 1230–8.CrossRefGoogle ScholarPubMed
5.Wilson, IC. Prange, AJ. McClane, TK. Rabon, AM. Lipton, MA. Thyroid-hormone enhancement of imipramine in nonretarded depressions. New Eng J Med 1970: 282: 1963–67.CrossRefGoogle ScholarPubMed
6.Prange, AJ. Therapeutic and theoretical implications of imipramine-hormone interactions in depressive disorders. Proceedings 5th World Congres of Psychiatry 1971;274: 1023–31.Google Scholar
7.Coppen, A, Whybrow, PC, Noguera, R, Muggs, R. Prange, AJ. The comparative antidepressant value of L-Tryptophan and imipramine with and without attempted potentiation by liothyronine. Arch Gen Psychiat 1972; 26: 234–41.CrossRefGoogle ScholarPubMed
8.Wheatley, D. Potentiation of amitriptyline by thyroid hormones. Arch Gen Psychiat 1972; 26: 229–33.CrossRefGoogle Scholar
9.Ogura, C. Okuma, T, Uchida, Y, Imai, S, Yogi, H, Sunami, Y. Combined thyroid (triiodothyronine) - tricyclic antidepressant treatment in depressive states. Fol Psychiat Neurol Jap 1974: 28/3: 179–86.Google ScholarPubMed
10.Banki, CM. T3 in the treatment of depression On Hetil 1975; 116: 2543–47.Google Scholar
11.Tsutsui, S, Yamazaki, Y, Namba, T. Tushima, M. Combined therapy of T3 and antidepressants in depression. J Int Med Res 1979: 7: 138–46.CrossRefGoogle ScholarPubMed
12.Goodwin, FK. Prange, AJ, Post, RM. Muscettola, G. Lipton, MA. Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders. Am J Psychiat 1982: 139/1: 34–8.Google ScholarPubMed
13.Schwarcz, G, Halaris, A. Baxter, L. Escobar, J. Thompson, M. Young, M. Normal thyroid function in desipramine nonresponders converted to responders by the addition of L-triiodothyronine. Am J Psychiat 1984; 141/12: 1614–16.Google ScholarPubMed
14.Gitlin, MJ. Weiner, H. Fairbanks, L, Hershman, JM. Freidfeld, N. Failure of T3 to potentiate tricyclic antidepressant response. J Aff Dis 1987: 13: 267–72.CrossRefGoogle ScholarPubMed
15.Earle, BV. Thyroid hormone and tricyclic antidepressants in resistent depressions. Am J Psychiat 1970; 126/11: 1667–9.CrossRefGoogle ScholarPubMed
16.Targum, SD. Greenberg, RD, Harmon, RL, Kessler, K, Salerian, AJ. Fram, DH. Thyroid hormone and the TRH stimulation test in refractory depression. J Clin Psychiat 1984; 45: 345–6.Google ScholarPubMed
17.Prange, AJ. The hypothalamic-pituitary-thyroid axis in affective Disorders. In: Meitzer, HY. ed. Psychopharmacology: The 3rd Generation of Progress. New York: Raven Press 1987.Google Scholar
18.Stein, D. Avni, J. Thyroid hormones in the treatment of affective disorders, (review article) Acta Psch Scand 1988: 77: 623–36.CrossRefGoogle Scholar
19.Loosen, PT. Hormones of the hypothalamic-pituitary-thyroid axis: a psychoneuroendocrine perspective. Pharmacopsychiat 1986: 19: 401–15.CrossRefGoogle Scholar
20.Gold, MS. Pottash, ALC. Extein, I. Hypothyroidism and Depression: evidence from complete thvroid function evaluation. JAMA 1981: 245/19: 1919–22.CrossRefGoogle Scholar
21.Sternbach, HA. Gold, MS. Pottash, AC. Extein, I. Thyroid failure and protirelin (TRH) test abnormalities in depressed outpatients. JAMA 1983: 249/12: 1618–20.CrossRefGoogle Scholar
22.Whybrow, PC. Prange, AJ. A hypothesis of thyroid-catecholamine-receptor interaction. Arch Gen Psychiat 1981: 38: 106–13.CrossRefGoogle ScholarPubMed
23.Sulser, F. Mode of action of antidepressant drugs. J Clin Psychiat 1983: 44:383–94.Google ScholarPubMed
24.Siever, L, Davis, KL. Overview: toward a dysregulation hypothesis of depression. Am J Psychiat 1985; 142: 1017–31.Google Scholar
25.Heninger, GR, Charney, DS. Mechanism of action of antidepressant treatments: implications for the etiology and treatment of depressive disorders. In: Meitzer, HY. ed. Psychopharmacology: The Third Generation of Progress. New York: Raven Press 1987: 535–44.Google Scholar